THERAPEUTICS ACQUISITION COR's ticker is RACA and the CUSIP is 88339T103. A total of 22 filers reported holding THERAPEUTICS ACQUISITION COR in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,000 | – | 220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 864,214 | $8,875,000 | 3.65% |
| BVF INC/IL | 2,772,226 | $28,498,000 | 1.07% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,000,000 | $10,274,000 | 1.05% |
| Boxer Capital, LLC | 2,500,000 | $25,675,000 | 0.91% |
| BERYLSON CAPITAL PARTNERS, LLC | 386,221 | $3,968,000 | 0.88% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,009,497 | $10,378,000 | 0.70% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,045,600 | $21,017,000 | 0.31% |
| FIRETHORN WEALTH PARTNERS, LLC | 29,485 | $303,000 | 0.25% |
| RA Capital Management | 1,098,318 | $11,284,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,400,000 | $24,672,000 | 0.10% |